Calpain 3 cleaves filamin C and regulates its ability to interact with γ‐ and δ‐sarcoglycans
- 7 August 2003
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 28 (4) , 472-483
- https://doi.org/10.1002/mus.10465
Abstract
Calpain 3 (C3) is the only muscle-specific member of the calcium-dependent protease family. Although neither its physiological function nor its in vivo substrates are known, C3 must be an important protein for normal muscle function as mutations in the C3 gene result in limb-girdle muscular dystrophy type 2A. Previous reports have shown that the ubiquitous calpains (μ and m) proteolyze filamins in nonmuscle cells. This observation suggests that the muscle-specific filamin C (FLNC) is a good candidate substrate for C3. Binding studies using recombinant proteins establish that recombinant C3 and native FLNC can interact. When these two proteins are translated in vitro and incubated together, C3 cleaves the C-terminal portion of FLNC. Cleavage is specific as C3 fails to cleave FLNC lacking its C-terminal hinge and putative dimerization domains. Cotransfection experiments in COS-7 cells confirm that C3 can cleave the C-terminus of FLNC in live cells. The C-terminus of FLNC has been shown to bind the cytoplasmic domains of both δ- and γ-sarcoglycan. Removal of the last 127 amino acids from FLNC, a protein that mimics FLNC after C3 cleavage, abolishes this interaction with the sarcoglycans. These studies confirm that C3 can cleave FLNC in vitro and suggest that FLNC may be an in vivo substrate for C3, functioning to regulate protein–protein interactions with the sarcoglycans. Thus, calpain-mediated remodeling of cytoskeletal–membrane interactions, such as those that occur during myoblast fusion and muscle repair, may involve regulation of FLNC–sarcoglycan interactions. Muscle Nerve 28: 472–483, 2003Keywords
This publication has 47 references indexed in Scilit:
- Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein TitinAmerican Journal of Human Genetics, 2002
- The Muscular Dystrophy with Myositis (mdm) Mouse Mutation Disrupts a Skeletal Muscle-Specific Domain of TitinGenomics, 2002
- Loss of Calpain 3 Proteolytic Activity Leads to Muscular Dystrophy and to Apoptosis-Associated Iκbα/Nuclear Factor κb Pathway Perturbation in MiceThe Journal of cell biology, 2000
- Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethoninNature Genetics, 2000
- Muscle-specific Calpain, p94, Responsible for Limb Girdle Muscular Dystrophy Type 2A, Associates with Connectin through IS2, a p94-specific SequenceJournal of Biological Chemistry, 1995
- Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2ACell, 1995
- Increase in the level of m-calpain correlates with the elevated cleavage of filamin during myogenic differentiation of embryonic muscle cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring.The Journal of cell biology, 1990
- Calpain abolishes the effect of filamin on the actomyosin system in plateletsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1987
- A Ca2+ion-activated protease possibly involved in myofibrillar protein turnover. Purification from porcine muscleBiochemistry, 1976